D5 KRM II 81
Alternative Names: D5-KRM-II-81Latest Information Update: 01 Apr 2022
At a glance
- Originator RespireRx Pharmaceuticals
- Class Antiepileptic drugs; Neuroprotectants; Small molecules
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Seizures